Bottle Label 320 mg/ 25 mg (71610 0327 60)
Valsartan And Hydrochlorothiazide
Product Images NDC 71610-327
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71610-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-1 (Figure 1)
This appears to be a chart showing different blood pressure measurements for a medication called Velsartan HCT. It appears that the medication is tested against a placebo and a control group (Aan Vasaan). The x-axis shows different baseline systolic blood pressure levels (SBP) and the y-axis shows the corresponding percentage of individuals who had a systolic blood pressure reading less than 140 mmHg. There is not enough context to understand the purpose of the study, but it appears it is evaluating the effectiveness of Velsartan HCT in lowering blood pressure.*
Figure-2 (Figure 2)
This appears to be a chart or table displaying blood pressure readings for different medication dosages. The column heading suggests that the goal is to keep diastolic blood pressure below 90 mmHg. The chart lists various dosages and combinations of medications, including valsartan and hydrochlorothiazide. It also includes a baseline reading of 105 mmHg.*
Figure-3 (Figure 3)
This appears to be a tabular section of a clinical study related to blood pressure medication. The table shows the medication dosages and placebo groups, along with their assigned codes or names. The first column includes the medication name and dosage (Valsaran HCT 320/25 mg and Valsartan 320 mg with Hydrochlorothiazide 25 mg). The subsequent columns have codes or names associated with the different intervention groups. The final row displays baseline systolic blood pressure (SBP) readings in mmHg.*
Figure-4 (Figure 4)
This appears to be a chart showing the baseline diastolic blood pressure (DBP) in millimeters of mercury (mmHg) for a study comparing the effects of Valsartan HCT (a combination of Valsartan 320mg and hydrochlorothiazide 25mg) to a placebo. The chart shows values of 95, 100, and 105 for the different treatments.*
Valsartan (Valsartan)
Hctz-str (Valsartn Hctz Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
